recombinant C1 esterase inhibitor; recombinant C1 INH

From Aaushi
Jump to navigation Jump to search

Indications

Dosage

  • SQ twice weekly

Pharmacokinetics

Notes

More general terms

References

  1. 1.0 1.1 1.2 Riedl MA, Grivcheva-Panovska V, Moldovan D et al. Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: A phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial. Lancet 2017 Jul 25; PMID: https://www.ncbi.nlm.nih.gov/pubmed/28754491
    Greve J, Hahn J. Recombinant human C1 esterase inhibitor for hereditary angio- oedema. Lancet 2017 Jul 25; PMID: https://www.ncbi.nlm.nih.gov/pubmed/28754495